Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel management in intensive care
ACTRN12623000112662Phase 3Completed
- Sponsor
- Austin Health
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of docusate sodium, sennosides and lactulose in bowel dysfunction (2 arms), sponsored by Austin Health. Primary endpoint: Diarrhoea. Started Feb 2023; status: completed.
02
Drugs
docusate sodiumsennosideslactulose
03
Conditions
bowel dysfunction
Beyond the preview
Go deeper on ACTRN12623000112662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12623000112662.